Latest News

Retrophin, Inc. (NasdaqGM:RTRX) ROA of -0.172613 & Quant Review

In trying to determine how profitable a company is per asset dollar, we can take a look at  the firm’s Return on Assets.  Return on assets is calculated by dividing a company’s net income (usually annual income) by its total assets, and is displayed as a percentage. At the time of writing, Retrophin, Inc. (NasdaqGM:RTRX) has -0.172613 ROA.  The measure is commonly used to compare the performance […]

by December 5, 2019

Inspecting the $1.46 Earnings Estimates for Marriott International, Inc. (NASDAQ:MAR)

Following some earnings data for Marriott International, Inc. (NASDAQ:MAR), we note that the current quarter EPS consensus estimate is 1.46. This EPS estimate is using data provided by 9 sell-side analysts polled by Zacks Research. This consensus estimate may vary from other data outlets providing consensus projections. Last quarter, the company reported a quarterly EPS of 1.47. Investors often pay […]

by December 5, 2019

Dollar Tree Inc. (DLTR) Elder Force Signal Dips Below Zero

Shares of Dollar Tree Inc. (DLTR) are being monitored closely as they have moved below the Elder Force zero line.  Elder’s Force Index (or EFI) uses volume and price change from previous close to determine the momentum behind a price move in a given direction. An increasing Force Index is indicative of strong interest in the direction of the price move while […]

by December 5, 2019

A Look at Some Alternative Metrics For Corbus Pharmaceuticals Holdings, Inc. (NasdaqGM:CRBP) as ROA Hits -1.016296

There are many different tools to determine whether a company is profitable or not. One of the most popular ratios is the “Return on Assets” (aka ROA). This score indicates how profitable a company is relative to its total assets. The Return on Assets for Corbus Pharmaceuticals Holdings, Inc. (NasdaqGM:CRBP) is -1.016296. This number is calculated by dividing net income […]

by December 5, 2019

TCR2 Therapeutics Inc. (NasdaqGS:TCRR) Valuation Score Card Under Review as ROA Reaches -0.713547

There are many different tools to determine whether a company is profitable or not. One of the most popular ratios is the “Return on Assets” (aka ROA). This score indicates how profitable a company is relative to its total assets. The Return on Assets for TCR2 Therapeutics Inc. (NasdaqGS:TCRR) is -0.713547. This number is calculated by dividing net income after […]

by December 5, 2019